NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ALSA Holdings

ALSA Holdings

London, Englandalsaventures.com

Overview

ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together outstanding entrepreneurs and world class academic researchers to help bring promising new treatments to market. We invest across a wide spectrum of therapeutic areas, targeting high unmet need with impactful outcomes for patients and society at large.

Year Founded

2019

Portfolio Companies

1

Investments

ALSA Holdings investments
CompanyDateStageLead
EpsilogenSep 2024Series B ExtensionCo-investor
EpsilogenMar 2022Series BCo-investor
EpsilogenApr 2020Series A ExtensionCo-investor
EpsilogenNov 2018Series ACo-investor

Key People

Bruce Goldsmith

Operating Partner

Julia Jones

Investment Manager

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.